- Position of new antidiabetics in clinical practice: SGLT2 vs DPP4 inhibitors2015 | First Faculty of Medicine
- Volba mezi inhibitory DPP4 a SGLT2 u diabetiků 2. typu nekompenzovaných na metforminu2018 | Second Faculty of Medicine
- Incretin based treatment - patophysiological remarks2017 | Faculty of Medicine in Pilsen
- Possible effect of OAS1 and TMPRSS6 but not DPP4 and ZNF335 polymorphisms on COVID-19 severity in the Czech population2023 | First Faculty of Medicine, Third Faculty of Medicine
- Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights2020 | First Faculty of Medicine
- Genetic variants associated with glycemic response to treatment with dipeptidylpeptidase 4 inhibitors2020 | Second Faculty of Medicine
- Role of sitagliptin in the treatment of type 2 diabetes based on the results of the TECOS study2016 | Second Faculty of Medicine
- Current role of gliptins in diabetes management2022 | Publication without faculty affiliation
- Type 2 diabetes mellitus and heart failure2016 | First Faculty of Medicine
- Gliptiny2018 | Third Faculty of Medicine
- Modern antidiabetics in synergy: fixed dose combination empagliflozin/linagliptin2017 | First Faculty of Medicine
- Structure-activity relationship and biochemical evaluation of novel fibroblast activation protein and prolyl endopeptidase inhibitors with α-ketoamide warheads2021 | Faculty of Science, Faculty of Physical Education and Sport, Central Library of Charles University
- Structure-activity relationship and biochemical evaluation of novel fibroblast activation protein and prolyl endopeptidase inhibitors with alpha-ketoamide warheads2021 | Faculty of Science, Faculty of Physical Education and Sport, Central Library of Charles University
- Studie CANVAS: kardiovaskulární a renální efekty canagliflozinu2017 | First Faculty of Medicine
- Species-specific real-time RT-PCR analysis of expression of stromal cell genes in a tumor xenotransplantation model in mice2017 | First Faculty of Medicine